Offshore
Video
โ Quiver Quantitative
JUST IN: The House will vote on Marjorie Taylor Greene's Gulf of America bill this week https://t.co/EygOBbElZi
tweet
JUST IN: The House will vote on Marjorie Taylor Greene's Gulf of America bill this week https://t.co/EygOBbElZi
tweet
โ Quiver Quantitative
RT @InsiderRadar: ๐จBREAKING: New Insider Purchases at $OGN
The CEO has just reported purchasing $300k of the company's stock, and the CFO has purchased $100k.
These are the first insider purchases we have seen by executives at $OGN in over 4 years.
tweet
RT @InsiderRadar: ๐จBREAKING: New Insider Purchases at $OGN
The CEO has just reported purchasing $300k of the company's stock, and the CFO has purchased $100k.
These are the first insider purchases we have seen by executives at $OGN in over 4 years.
tweet
โ Dimitry Nakhla | Babylon Capitalยฎ
RT @DimitryNakhla: The recent stock market correction hit fast โ a 10% drop in just 16 days, one of the quickest on record $SPY
The rapid plunge might shake investor confidence, making it tough to spot solid opportunities
Here are 10 high-quality stocks worthy of becoming core holdings๐งต
tweet
RT @DimitryNakhla: The recent stock market correction hit fast โ a 10% drop in just 16 days, one of the quickest on record $SPY
The rapid plunge might shake investor confidence, making it tough to spot solid opportunities
Here are 10 high-quality stocks worthy of becoming core holdings๐งต
tweet
Offshore
Photo
โ Dimitry Nakhla | Babylon Capitalยฎ
A quality valuation analysis on $NVO ๐ง๐ฝโโ๏ธ
โขNTM P/E Ratio: 17.09x
โข10-Year Mean: 25.04x
โขNTM FCF Yield: 4.17%
โข10-Year Mean: 3.74%
As you can see, $NVO appears to be trading below fair value
Going forward, investors can receive ~46% MORE in earnings per share & ~11% MORE in FCF per share ๐ง ***
Before we get into valuation, letโs take a look at why $NVO is a great business
BALANCE SHEETโ
โขCash & Short-Term Inv: $3.65B
โขLong-Term Debt: $11.70B
$NVO has a strong balance sheet, an AA- S&P Credit Rating & 73x FFO Interest Coverage
RETURN ON CAPITALโ
โข2020: 71.0%
โข2021: 57.7%
โข2022: 65.0%
โข2023: 72.8%
โข2024: 55.6%
RETURN ON EQUITYโ
โข2020: 69.7%
โข2021: 71.2%
โข2022: 72.0%
โข2023: 88.1%
โข2024: 80.8%
$NVO has strong return metrics, highlighting the financial efficiency of the business
REVENUESโ
โข2014: $14.43B
โข2024: $40.34B
โขCAGR: 10.82%
FREE CASH FLOWโ
โข2014: $4.50B
โข2024: $10.25B
โขCAGR: 8.58%
NORMALIZED EPSโ
โข2014: $0.78
โข2024: $3.16
โขCAGR: 15.01%
SHARE BUYBACKSโ
โข2014 Shares Outstanding: 5.26B
โขLTM Shares Outstanding: 4.46B
By reducing its shares outstanding ~15.2%, $NVO increased its EPS by ~17.9% (assuming 0 growth)
MARGINSโ
โขLTM Gross Margins: 85.0%
โขLTM Operating Margins: 48.2%
โขLTM Net Income Margins: 34.8%
***NOW TO VALUATION ๐ง
As stated above, investors can expect to receive ~46% MORE in EPS & ~11% MORE in FCF per share
Using Benjamin Grahamโs 2G rule of thumb, $NVO has to grow earnings at an 8.55% CAGR over the next several years to justify its valuation
Today, analysts anticipate 2025 - 2027 EPS growth over the next few years to be more than the (8.55%) required growth rate:
2025E: $4.04 (21.9% YoY) *FY Dec
2026E: $4.78 (11.8% YoY)
2027E: $5.45 (12.6% YoY)
$NVO has an excellent track record of meeting analyst estimates ~2 years out, but letโs assume $NVO ends 2027 with $4.90 in EPS (-10% below current estimates) & see its CAGR potential assuming different multiples
23x P/E: $112.70๐ต โฆ ~24.4% CAGR
22x P/E: $107.80๐ต โฆ ~22.4% CAGR
21x P/E: $102.90๐ต โฆ ~20.4% CAGR
20x P/E: $98.00๐ต โฆ ~18.2% CAGR
19x P/E: $93.10๐ต โฆ ~16.0% CAGR
As you can see, $NVO appears to have attractive return potential IF we assume >20x earnings (a multiple below its 10-year mean, & a multiple justified by its growth rate & quality)
Today at $66๐ต $NVO is a strong consideration for investment
By assuming a 20x end multiple & 2027 EPS -10% below analyst estimates, we ensure a good margin of safety to compensate for the inherent risks in the biotech / biopharma space (lack of predictability, R&D risk, patent expirations, etc.)
#stocks #investing
*Financials in USD
___
๐๐๐๐๐๐๐๐๐๐โผ๏ธ: ๐๐ก๐ข๐ฌ ๐ข๐ฌ ๐๐๐ ๐๐ง๐ฏ๐๐ฌ๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ฏ๐ข๐๐. ๐๐๐๐ฒ๐ฅ๐จ๐ง ๐๐๐ฉ๐ข๐ญ๐๐ฅยฎ ๐๐ง๐ ๐ข๐ญ๐ฌ ๐ซ๐๐ฉ๐ซ๐๐ฌ๐๐ง๐ญ๐๐ญ๐ข๐ฏ๐๐ฌ ๐ฆ๐๐ฒ ๐ก๐๐ฏ๐ ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ฌ๐๐๐ฎ๐ซ๐ข๐ญ๐ข๐๐ฌ ๐๐ข๐ฌ๐๐ฎ๐ฌ๐ฌ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐๐๐ญ.
๐๐ก๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐จ๐ง๐ญ๐๐ข๐ง๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐๐๐ญ ๐ข๐ฌ ๐ข๐ง๐ญ๐๐ง๐๐๐ ๐๐จ๐ซ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐ฉ๐ฎ๐ซ๐ฉ๐จ๐ฌ๐๐ฌ ๐จ๐ง๐ฅ๐ฒ ๐๐ง๐ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ง๐จ๐ญ ๐๐ ๐๐จ๐ง๐ฌ๐ญ๐ซ๐ฎ๐๐ ๐๐ฌ ๐ข๐ง๐ฏ๐๐ฌ๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ฏ๐ข๐๐ ๐ญ๐จ ๐ฆ๐๐๐ญ ๐ญ๐ก๐ ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐ง๐๐๐๐ฌ ๐จ๐ ๐๐ง๐ฒ ๐ข๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐๐ฅ ๐จ๐ซ ๐ฌ๐ข๐ญ๐ฎ๐๐ญ๐ข๐จ๐ง. ๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐๐จ๐ซ๐ฆ๐๐ง๐๐ ๐ข๐ฌ ๐ง๐จ ๐ ๐ฎ๐๐ซ๐๐ง๐ญ๐๐ ๐จ๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐ซ๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ.
๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐จ๐ง๐ญ๐๐ข๐ง๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐๐๐ญ ๐ก๐๐ฌ ๐๐๐๐ง ๐จ๐๐ญ๐๐ข๐ง๐๐ ๐๐ซ๐จ๐ฆ ๐ฌ๐จ๐ฎ๐ซ๐๐๐ฌ ๐๐๐ฅ๐ข๐๐ฏ๐๐ ๐ญ๐จ ๐๐ ๐ซ๐๐ฅ๐ข๐๐๐ฅ๐, ๐๐ฎ๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐ ๐ฎ๐๐ซ๐๐ง๐ญ๐๐๐ ๐๐ฌ ๐ญ๐จ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐๐ง๐๐ฌ๐ฌ ๐จ๐ซ ๐๐๐๐ฎ๐ซ๐๐๐ฒ.
tweet
A quality valuation analysis on $NVO ๐ง๐ฝโโ๏ธ
โขNTM P/E Ratio: 17.09x
โข10-Year Mean: 25.04x
โขNTM FCF Yield: 4.17%
โข10-Year Mean: 3.74%
As you can see, $NVO appears to be trading below fair value
Going forward, investors can receive ~46% MORE in earnings per share & ~11% MORE in FCF per share ๐ง ***
Before we get into valuation, letโs take a look at why $NVO is a great business
BALANCE SHEETโ
โขCash & Short-Term Inv: $3.65B
โขLong-Term Debt: $11.70B
$NVO has a strong balance sheet, an AA- S&P Credit Rating & 73x FFO Interest Coverage
RETURN ON CAPITALโ
โข2020: 71.0%
โข2021: 57.7%
โข2022: 65.0%
โข2023: 72.8%
โข2024: 55.6%
RETURN ON EQUITYโ
โข2020: 69.7%
โข2021: 71.2%
โข2022: 72.0%
โข2023: 88.1%
โข2024: 80.8%
$NVO has strong return metrics, highlighting the financial efficiency of the business
REVENUESโ
โข2014: $14.43B
โข2024: $40.34B
โขCAGR: 10.82%
FREE CASH FLOWโ
โข2014: $4.50B
โข2024: $10.25B
โขCAGR: 8.58%
NORMALIZED EPSโ
โข2014: $0.78
โข2024: $3.16
โขCAGR: 15.01%
SHARE BUYBACKSโ
โข2014 Shares Outstanding: 5.26B
โขLTM Shares Outstanding: 4.46B
By reducing its shares outstanding ~15.2%, $NVO increased its EPS by ~17.9% (assuming 0 growth)
MARGINSโ
โขLTM Gross Margins: 85.0%
โขLTM Operating Margins: 48.2%
โขLTM Net Income Margins: 34.8%
***NOW TO VALUATION ๐ง
As stated above, investors can expect to receive ~46% MORE in EPS & ~11% MORE in FCF per share
Using Benjamin Grahamโs 2G rule of thumb, $NVO has to grow earnings at an 8.55% CAGR over the next several years to justify its valuation
Today, analysts anticipate 2025 - 2027 EPS growth over the next few years to be more than the (8.55%) required growth rate:
2025E: $4.04 (21.9% YoY) *FY Dec
2026E: $4.78 (11.8% YoY)
2027E: $5.45 (12.6% YoY)
$NVO has an excellent track record of meeting analyst estimates ~2 years out, but letโs assume $NVO ends 2027 with $4.90 in EPS (-10% below current estimates) & see its CAGR potential assuming different multiples
23x P/E: $112.70๐ต โฆ ~24.4% CAGR
22x P/E: $107.80๐ต โฆ ~22.4% CAGR
21x P/E: $102.90๐ต โฆ ~20.4% CAGR
20x P/E: $98.00๐ต โฆ ~18.2% CAGR
19x P/E: $93.10๐ต โฆ ~16.0% CAGR
As you can see, $NVO appears to have attractive return potential IF we assume >20x earnings (a multiple below its 10-year mean, & a multiple justified by its growth rate & quality)
Today at $66๐ต $NVO is a strong consideration for investment
By assuming a 20x end multiple & 2027 EPS -10% below analyst estimates, we ensure a good margin of safety to compensate for the inherent risks in the biotech / biopharma space (lack of predictability, R&D risk, patent expirations, etc.)
#stocks #investing
*Financials in USD
___
๐๐๐๐๐๐๐๐๐๐โผ๏ธ: ๐๐ก๐ข๐ฌ ๐ข๐ฌ ๐๐๐ ๐๐ง๐ฏ๐๐ฌ๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ฏ๐ข๐๐. ๐๐๐๐ฒ๐ฅ๐จ๐ง ๐๐๐ฉ๐ข๐ญ๐๐ฅยฎ ๐๐ง๐ ๐ข๐ญ๐ฌ ๐ซ๐๐ฉ๐ซ๐๐ฌ๐๐ง๐ญ๐๐ญ๐ข๐ฏ๐๐ฌ ๐ฆ๐๐ฒ ๐ก๐๐ฏ๐ ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ฌ๐๐๐ฎ๐ซ๐ข๐ญ๐ข๐๐ฌ ๐๐ข๐ฌ๐๐ฎ๐ฌ๐ฌ๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐๐๐ญ.
๐๐ก๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐จ๐ง๐ญ๐๐ข๐ง๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐๐๐ญ ๐ข๐ฌ ๐ข๐ง๐ญ๐๐ง๐๐๐ ๐๐จ๐ซ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐ฉ๐ฎ๐ซ๐ฉ๐จ๐ฌ๐๐ฌ ๐จ๐ง๐ฅ๐ฒ ๐๐ง๐ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ง๐จ๐ญ ๐๐ ๐๐จ๐ง๐ฌ๐ญ๐ซ๐ฎ๐๐ ๐๐ฌ ๐ข๐ง๐ฏ๐๐ฌ๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ฏ๐ข๐๐ ๐ญ๐จ ๐ฆ๐๐๐ญ ๐ญ๐ก๐ ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐ง๐๐๐๐ฌ ๐จ๐ ๐๐ง๐ฒ ๐ข๐ง๐๐ข๐ฏ๐ข๐๐ฎ๐๐ฅ ๐จ๐ซ ๐ฌ๐ข๐ญ๐ฎ๐๐ญ๐ข๐จ๐ง. ๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐๐จ๐ซ๐ฆ๐๐ง๐๐ ๐ข๐ฌ ๐ง๐จ ๐ ๐ฎ๐๐ซ๐๐ง๐ญ๐๐ ๐จ๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐ซ๐๐ฌ๐ฎ๐ฅ๐ญ๐ฌ.
๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐จ๐ง๐ญ๐๐ข๐ง๐๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ญ๐ฐ๐๐๐ญ ๐ก๐๐ฌ ๐๐๐๐ง ๐จ๐๐ญ๐๐ข๐ง๐๐ ๐๐ซ๐จ๐ฆ ๐ฌ๐จ๐ฎ๐ซ๐๐๐ฌ ๐๐๐ฅ๐ข๐๐ฏ๐๐ ๐ญ๐จ ๐๐ ๐ซ๐๐ฅ๐ข๐๐๐ฅ๐, ๐๐ฎ๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐ ๐ฎ๐๐ซ๐๐ง๐ญ๐๐๐ ๐๐ฌ ๐ญ๐จ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐๐ง๐๐ฌ๐ฌ ๐จ๐ซ ๐๐๐๐ฎ๐ซ๐๐๐ฒ.
tweet
โ Wall St Engine
Bill Ackman floats the idea: if Trump cut China tariffs to 20% and raised them graduallyโ0.5%/mo in year 1, 1% in year 2, 1.5% in year 3โitโd give firms time to move supply chains, while pressuring China to reform. Hikes could pause or reverse if trade practices improve.
tweet
Bill Ackman floats the idea: if Trump cut China tariffs to 20% and raised them graduallyโ0.5%/mo in year 1, 1% in year 2, 1.5% in year 3โitโd give firms time to move supply chains, while pressuring China to reform. Hikes could pause or reverse if trade practices improve.
What if @realDonaldTrump were to announce that China tariffs would immediately be reduced to 20% and then escalate thereafter by 0.5% per month for next 12 months, and then by 1% per month for the next 12 months, and then by 1.5% per month for the next 12 months and so on?
To the extent that China modifies its unfair trade practices, the increases could stop and potentially be reversed depending upon the degree of improvement in its trade policies.
This approach would incentivize companies to relocate their supply chains from China while enabling them to continue to operate profitably during the transition.
China would be incentivized to make a good deal with @realDonaldTrump as promptly as practicable while the risk of a dramatic shock to the US and global economies would be greatly reduced if not eliminated. - Bill Ackmantweet
twitter.com
undefined
undefined
Offshore
Photo
โ Wall St Engine
S&P 500 Closing Bell Heatmap (May 06, 2025)
$SPY -0.83% ๐ฅ
$QQQ -0.93% ๐ฅ
$DJI -0.95% ๐ฅ
$IWM -1.09% ๐ฅ
tweet
S&P 500 Closing Bell Heatmap (May 06, 2025)
$SPY -0.83% ๐ฅ
$QQQ -0.93% ๐ฅ
$DJI -0.95% ๐ฅ
$IWM -1.09% ๐ฅ
S&P 500 Opening Bell Heatmap (May 06, 2025)
$SPY -1.01% ๐ฅ
$QQQ -1.33% ๐ฅ
$DJI -0.75% ๐ฅ
$IWM -1.10% ๐ฅ - Wall St Enginetweet
Offshore
Photo
โ Wall St Engine
$WYNN Resorts Q1'25 Earnings Highlights
๐น Revenue: $1.70B (Est: $1.75B) ๐ด
๐น Adj EPS: $1.07 (Est: $1.31) ๐ด
๐น Adj Net Income: $113.1M (Est: $137.2M) ๐ด
๐น Adjusted Property EBITDAR: $532.9M (Est: $561.8M) ๐ด
Segment Breakdown
Macau; Wynn Palace:
๐น Revenue: $535.9M (vs. $586.9M YoY)
๐น EBITDAR: $161.9M (vs. $202.4M YoY)
๐น VIP win rate: 2.61% (vs. 3.30% YoY)
๐น Mass win rate: 24.8% (vs. 24.5% YoY)
Wynn Macau:
๐น Revenue: $330.0M (vs. $411.7M YoY)
๐น EBITDAR: $90.2M (vs. $137.2M YoY)
๐น VIP win rate: 1.09% (vs. 3.39% YoY)
๐น Mass win rate: 18.7% (vs. 19.4% YoY)
U.S. Properties
๐น Las Vegas Operations:
๐น Revenue: $625.3M (vs. $636.5M YoY)
๐น EBITDAR: $223.4M (vs. $246.3M YoY)
๐น Table win %: 24.3% (within expected 22โ26%)
Encore Boston Harbor:
๐น Revenue: $209.2M (vs. $217.8M YoY)
๐น EBITDAR: $57.5M (vs. $63.1M YoY)
๐น Table win %: 20.5% (within expected 18โ22%)
Strategic & Financial Updates
๐ธ Declared $0.25/share dividend, payable May 30, 2025
๐ธ Repurchased 2.36M shares for $200M in Q1; $613M buyback authorization remaining
๐ธ UAE Project (Wynn Al Marjan Island): hotel tower reached 47th floor; $682.9M contributed to date
๐ธ Board remains confident in long-term capital returns; continued free cash flow strength from Macau
tweet
$WYNN Resorts Q1'25 Earnings Highlights
๐น Revenue: $1.70B (Est: $1.75B) ๐ด
๐น Adj EPS: $1.07 (Est: $1.31) ๐ด
๐น Adj Net Income: $113.1M (Est: $137.2M) ๐ด
๐น Adjusted Property EBITDAR: $532.9M (Est: $561.8M) ๐ด
Segment Breakdown
Macau; Wynn Palace:
๐น Revenue: $535.9M (vs. $586.9M YoY)
๐น EBITDAR: $161.9M (vs. $202.4M YoY)
๐น VIP win rate: 2.61% (vs. 3.30% YoY)
๐น Mass win rate: 24.8% (vs. 24.5% YoY)
Wynn Macau:
๐น Revenue: $330.0M (vs. $411.7M YoY)
๐น EBITDAR: $90.2M (vs. $137.2M YoY)
๐น VIP win rate: 1.09% (vs. 3.39% YoY)
๐น Mass win rate: 18.7% (vs. 19.4% YoY)
U.S. Properties
๐น Las Vegas Operations:
๐น Revenue: $625.3M (vs. $636.5M YoY)
๐น EBITDAR: $223.4M (vs. $246.3M YoY)
๐น Table win %: 24.3% (within expected 22โ26%)
Encore Boston Harbor:
๐น Revenue: $209.2M (vs. $217.8M YoY)
๐น EBITDAR: $57.5M (vs. $63.1M YoY)
๐น Table win %: 20.5% (within expected 18โ22%)
Strategic & Financial Updates
๐ธ Declared $0.25/share dividend, payable May 30, 2025
๐ธ Repurchased 2.36M shares for $200M in Q1; $613M buyback authorization remaining
๐ธ UAE Project (Wynn Al Marjan Island): hotel tower reached 47th floor; $682.9M contributed to date
๐ธ Board remains confident in long-term capital returns; continued free cash flow strength from Macau
tweet